copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
New dementia risk score helps identify people at risk The UK Biobank Dementia Risk Score, or UKBDRS for short, outperformed three other widely used risk scores originally developed in Australia (ANU-ADRI), Finland (CAIDE), and the UK (DRS), the findings show
Development and validation of a dementia risk score in the UK Biobank . . . In this study, we address these limitations by using data from the UK Biobank (UKB) study to develop a novel 14-year dementia risk score specific to a mid-life UK population, which we refer to as the UK Biobank Dementia Risk Score (UKBDRS)
New risk score strongly predicts dementia chances Within 14 years, 3813 (nearly 2%) and 93 (just over 3%) participants developed dementia in the UK Biobank and Whitehall II groups, respectively The researchers suggest that the accuracy of their risk score could be further improved by adding cognitive tests, a brain scan, and a blood test for indicators of neurodegeneration
Scientists develop most accurate way of identifying dementia risk LONDON — British scientists have developed the most accurate method to date for identifying individuals who will develop dementia The newly introduced “dementia risk score” strongly predicts the likelihood of individuals over the age of 50 developing this debilitating disease within a 14-year span
New risk score strongly predicts dementia chances within 14 years The UK Biobank Dementia Risk Score, or UKBDRS for short, outperformed three other widely used risk scores originally developed in Australia (ANU-ADRI), Finland (CAIDE), and the UK (DRS), the findings show
New dementia risk score can spot disease starting at age 50 In total, 3,813 people (1 7%) in the U K Biobank cohort and 93 people (3 2%) in Whitehall II developed dementia The tool looks at 11 variables that could predict if a person will develop
Approved Research - UK Biobank This tool has been developed by pooling 10 well-known international datasets from Australia, the Netherlands, Singapore, the UK, and the USA 2) To develop a midlife version of the DemNCD risk tool by using midlife participant data from UK Biobank
Development and validation of a dementia risk score in the UK Biobank . . . OBJECTIVE: We aimed to develop and validate a novel dementia risk score for a midlife UK population, using two cohorts: the UK Biobank, and UK Whitehall II study METHODS: We divided the UK Biobank cohort into a training (n=176 611, 80%) and test sample (n=44 151, 20%) and used the Whitehall II cohort (n=2934) for external validation